CNVVF
Price
$3.00
Change
-$0.08 (-2.60%)
Updated
Mar 26 closing price
Capitalization
5.48B
GKOS
Price
$96.68
Change
+$1.25 (+1.31%)
Updated
Apr 25 closing price
Capitalization
4.61B
2 days until earnings call
Ad is loading...

CNVVF vs GKOS

Header iconCNVVF vs GKOS Comparison
Open Charts CNVVF vs GKOSBanner chart's image
ConvaTec Group
Price$3.00
Change-$0.08 (-2.60%)
Volume$2K
Capitalization5.48B
Glaukos
Price$96.68
Change+$1.25 (+1.31%)
Volume$545.21K
Capitalization4.61B
CNVVF vs GKOS Comparison Chart
Loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNVVF vs. GKOS commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNVVF is a Hold and GKOS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (CNVVF: $3.00 vs. GKOS: $96.68)
Brand notoriety: CNVVF and GKOS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CNVVF: 55% vs. GKOS: 50%
Market capitalization -- CNVVF: $5.48B vs. GKOS: $4.61B
CNVVF [@Medical Specialties] is valued at $5.48B. GKOS’s [@Medical Specialties] market capitalization is $4.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNVVF’s FA Score shows that 0 FA rating(s) are green whileGKOS’s FA Score has 0 green FA rating(s).

  • CNVVF’s FA Score: 0 green, 5 red.
  • GKOS’s FA Score: 0 green, 5 red.
According to our system of comparison, GKOS is a better buy in the long-term than CNVVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 5 TA indicator(s) are bullish.

  • GKOS’s TA Score: 5 bullish, 4 bearish.

Price Growth

CNVVF (@Medical Specialties) experienced а 0.00% price change this week, while GKOS (@Medical Specialties) price change was +7.11% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.62%. For the same industry, the average monthly price growth was -3.92%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

GKOS is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+5.62% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNVVF($5.48B) has a higher market cap than GKOS($4.61B). CNVVF YTD gains are higher at: 3.806 vs. GKOS (-35.521). CNVVF has higher annual earnings (EBITDA): 356M vs. GKOS (-82.12M). GKOS has more cash in the bank: 295M vs. CNVVF (144M). GKOS has less debt than CNVVF: GKOS (384M) vs CNVVF (1.3B). CNVVF has higher revenues than GKOS: CNVVF (2.07B) vs GKOS (315M).
CNVVFGKOSCNVVF / GKOS
Capitalization5.48B4.61B119%
EBITDA356M-82.12M-434%
Gain YTD3.806-35.521-11%
P/E Ratio85.47N/A-
Revenue2.07B315M658%
Total Cash144M295M49%
Total Debt1.3B384M339%
FUNDAMENTALS RATINGS
CNVVF vs GKOS: Fundamental Ratings
CNVVF
GKOS
OUTLOOK RATING
1..100
5017
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
5943
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
5282
P/E GROWTH RATING
1..100
9254
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNVVF's Valuation (50) in the null industry is in the same range as GKOS (50) in the Medical Specialties industry. This means that CNVVF’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (43) in the Medical Specialties industry is in the same range as CNVVF (59) in the null industry. This means that GKOS’s stock grew similarly to CNVVF’s over the last 12 months.

GKOS's SMR Rating (92) in the Medical Specialties industry is in the same range as CNVVF (95) in the null industry. This means that GKOS’s stock grew similarly to CNVVF’s over the last 12 months.

CNVVF's Price Growth Rating (52) in the null industry is in the same range as GKOS (82) in the Medical Specialties industry. This means that CNVVF’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for CNVVF (92) in the null industry. This means that GKOS’s stock grew somewhat faster than CNVVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOS
RSI
ODDS (%)
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
70%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 20 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
74%
View a ticker or compare two or three
Ad is loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIOHX15.120.06
+0.40%
Nuveen International Opps I
DRIOX9.350.02
+0.21%
Driehaus International Small Cap Growth
GFVCX14.29N/A
N/A
Goldman Sachs Focused Value C
QRSIX37.02-0.08
-0.22%
FPA Queens Road Small Cap Value Instl
MVCAX28.45-0.15
-0.52%
MFS Mid Cap Value A

CNVVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNVVF has been loosely correlated with FLMNY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNVVF jumps, then FLMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVF
1D Price
Change %
CNVVF100%
N/A
FLMNY - CNVVF
36%
Loosely correlated
N/A
SAFLY - CNVVF
32%
Poorly correlated
N/A
GKOS - CNVVF
24%
Poorly correlated
+1.31%
EW - CNVVF
23%
Poorly correlated
+1.21%
OFIX - CNVVF
22%
Poorly correlated
+1.72%
More